Additionally, in a number of malignancies, PRAME expression levels were closely associated with immunological neoantigens, immune infiltration, immune score, immune checkpoint, tumor mutation burden, microsatellite instability, mismatch repair, and DNA methyltransferase. The gene discussed is PRAME; the disease is neoplasm.